AcroViz Inc.
Company Details
About: AcroViz develops novel imaging biomarkers for brain health, in an effort to prolong human health span with state-of-art technologies.
Comprising eminent academia researchers and experienced industrial professionals, the team is devoted to advancing scientific research, maximizing its clinical significance and application, as well as commercialization to achieve extended positive impact.
The first product: AcroViz Axonal Brain Age – Brain Health Report, is the first to the market that adopting diffusion Magnetic Resonance Imaging (dMRI) and Machine Learning techniques to provide accurate and objective brain health assessment, which can serve as a Mild Cognitive Impairment (MCI) marker in predicting the risk and prognosis of dementia, such as Alzheimer's Disease (AD).
Web acroviz.com/en/
FB www.facebook.com/acroviz
IG www.instagram.com/acroviz_brainhealth
YT www.youtube.com/@acroviz
LINE https://lin.ee/T2Ttyyj
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
AcroViz Inc. | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.